Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-09
2005-08-09
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S279000
Reexamination Certificate
active
06927220
ABSTRACT:
The invention relates to 6- or 7-bicyclic-substituted 4-amino-subsituted pyridopyrimidines and to pharmaceutically acceptable salts, prodrugs and hydrates thereof. The invention also relates to pharmaceutical compositions containing the compounds and to methods of treating hyperproliferative disorders abnormal cell growth in a mammal by administering the compounds.
REFERENCES:
patent: 6123939 (2000-09-01), Shawver
patent: 6297238 (2001-10-01), Doyle et al.
patent: 6492383 (2002-12-01), Munchhof et al.
patent: 2005/0038047 (2005-02-01), Edwards et al.
patent: 2345486 (1999-07-01), None
patent: WO 9640142 (1993-12-01), None
patent: WO 9519774 (1995-07-01), None
patent: WO9521613 (1995-08-01), None
patent: WO 9713771 (1997-04-01), None
patent: WO 9738983 (1997-10-01), None
patent: WO 9802437 (1998-01-01), None
patent: WO 9802438 (1998-01-01), None
patent: WO 9935132 (1999-07-01), None
patent: WO 9935146 (1999-07-01), None
patent: WO 0104111 (2001-01-01), None
Receptor Tyrosine Kinases (RTKs) chart from http://www.kinase.com/mammalian/rtks.pdf downloaded from the Internet Feb. 26, 2004.
Abstract of Kelloff, Cancer Epidemiol Biomarkers Prevention, vol. 5, (8) pp. 657-666, 1966.
Abstract of Lemoine et al, J.Patho1, Jan. 1992, 166(1) 7-12.
Abstract of Stephan et a1., Puerto Rico Health Sciences Journal, vol. 15( 3) pp. 169-178, 1996.
Sariola Nature Medicine, vol. 5, No. 1, Jan. 1999.
Holt, http://www.biopathics.com
eutriceuticals2[1].htm.
Angiogenesis by Kate L Pugh www.earth.li/˜kake/maths/mathbiol/angiogenesis.html.
Jiang, Journal of Biological Chemistry, vol. 278, No. 34, pp. 31964-31971, 2003.
Abstract of Chou et al Circulation. 105 (3): 373, 2002.
R. Roskoski,BBRC,vol. 319 (2004): 1-11 “The ErbB/HER receptor protein-tyrosine kinases and cancer.”
European Search Report for European Patent Application No. EP 02 25 2428; 2 pages.
Bhattacharya Samit K.
Kath John C.
Morris Joel
Berch Mark L.
Butterfield Garth
Pfizer Inc
Richardson Peter C.
Smolizza Christian M.
LandOfFree
Bicyclic-substituted 4-amino-pyridopyrimidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic-substituted 4-amino-pyridopyrimidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic-substituted 4-amino-pyridopyrimidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3523837